isoniazid has been researched along with oxadiazoles in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (16.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (8.33) | 29.6817 |
2010's | 6 (50.00) | 24.3611 |
2020's | 3 (25.00) | 2.80 |
Authors | Studies |
---|---|
BALLONOFF, LB; FEINSTEIN, RN; SEAHOLM, JE | 1 |
ASPEVIK, E; EVENSTAD, E; HAUKENES, G; SMITH, AE | 1 |
Bayrak, H; Demirbas, A; Demirbas, N; Karaoglu, SA | 1 |
Gilani, SJ; Khan, SA; Siddiqui, N | 1 |
Basso, LA; Calixto, JB; Campos, MM; de França Lopes, LG; Dos Santos Junior, A; Dos Santos, AJ; Rodrigues-Junior, VS; Santos, DS; Schneider, CZ; Sousa, EH; Souto, AA | 1 |
Baeza, I; Barrios-Payán, J; Bini, EI; Hernández-Pando, R; Marquina, B; Mata-Espinosa, D; Molina-Salinas, GM; Navarrete-Vázquez, G; Ramos-Espinosa, O | 1 |
Alling, T; Bailey, MA; Casey, A; Early, JV; Files, M; Gonzalez Valcarcel, IC; Martinez-Grau, MA; Ollinger, J; Ovechkina, Y; Parish, T; Vieth, M | 1 |
Huszár, S; Janoušek, J; Korduláková, J; Krátký, M; Madacki, J; Mikušová, K; Stolaříková, J; Švarcová, M; Trejtnar, F; Vinšová, J; Vosátka, R | 1 |
Ambhore, AN; Dawane, BS; Gacche, RN; Gaikwad, MV; Hebade, MJ; Hese, SV; Kadam, SN; Kamble, RD; Kamble, SS; Meshram, RJ | 1 |
Bleotu, C; Diaconu, CC; Hanganu, A; Ionita, P; Limban, C; Matei, L; Nemeș, RM; Nicolau, I; Nuta, DC; Păun, A; Radulescu, C; Tatibouët, A; Zarafu, I | 1 |
Parish, T; Thayer, MB | 1 |
Abd Ghani, MS; Awang, K; Azmi, MN; Hasmaruddin, NS; Hassan, MZ; Mat Ali, NA; Mohamad, S; Osman, H; Parumasivam, T | 1 |
12 other study(ies) available for isoniazid and oxadiazoles
Article | Year |
---|---|
EFFECT ON CATALASE IN VIVO AND IN VITRO OF COMPOUNDS RELATED TO AMINOTRIAZOLE. ANL-6823.
Topics: Amitrole; Azides; Azoles; Catalase; Enzyme Inhibitors; Erythrocytes; Imidazoles; In Vitro Techniques; Isoniazid; Kidney; Liver; Oxadiazoles; Oxazoles; Oxidation-Reduction; Pentylenetetrazole; Pharmacology; Pyrazoles; Rats; Research; Thiazoles; Triazoles | 1964 |
A PRELIMINARY REPORT ON A NEW ANTITUBERCULOUS DRUG 4-AMINO-2-HYDROXY-PHENYL-1, 3, 4,-OXADIAZOL-2-OL WS 127.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Biomedical Research; Blood; Cycloserine; Drug Resistance; Drug Resistance, Microbial; Ethionamide; Isoniazid; Mice; Oxadiazoles; Pharmacology; Pneumothorax; Pneumothorax, Artificial; Pyrazinamide; Radiography, Thoracic; Sputum; Streptomycin; Toxicology; Tuberculosis; Tuberculosis, Pulmonary; Urine | 1964 |
Synthesis of some new 1,2,4-triazoles starting from isonicotinic acid hydrazide and evaluation of their antimicrobial activities.
Topics: Anti-Infective Agents; Bacteria; Isoniazid; Mannich Bases; Microbial Sensitivity Tests; Molecular Structure; Oxadiazoles; Structure-Activity Relationship; Triazoles; Yeasts | 2009 |
Synthesis and pharmacological evaluation of condensed heterocyclic 6-substituted 1,2,4-triazolo-[3,4-b]-1,3,4-thiadiazole and 1,3,4-oxadiazole derivatives of isoniazid.
Topics: Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Isoniazid; Lipid Peroxidation; Oxadiazoles; Thiadiazoles | 2010 |
Activity of IQG-607, a new orally active compound, in a murine model of Mycobacterium tuberculosis infection.
Topics: Animals; Antitubercular Agents; Bacterial Load; Disease Models, Animal; Drug Evaluation, Preclinical; Ferrous Compounds; Isoniazid; Lung; Lung Diseases; Male; Mice; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxadiazoles; Tuberculosis | 2012 |
Therapeutic efficacy of liposomes containing 4-(5-pentadecyl-1,3,4-oxadiazol-2-yl)pyridine in a murine model of progressive pulmonary tuberculosis.
Topics: Animals; Antitubercular Agents; Cholesterol; Disease Models, Animal; Isoniazid; Liposomes; Male; Mice; Mice, Inbred BALB C; Mycobacterium tuberculosis; Oxadiazoles; Phosphatidic Acids; Phosphatidylcholines; Pyridines; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2015 |
Oxadiazoles Have Butyrate-Specific Conditional Activity against Mycobacterium tuberculosis.
Topics: Animals; Antitubercular Agents; Butyric Acid; Cell Survival; Chlorocebus aethiops; Culture Media; Glucose; High-Throughput Screening Assays; Isoniazid; Kanamycin; Levofloxacin; Metabolic Networks and Pathways; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxadiazoles; Small Molecule Libraries; Species Specificity; Structure-Activity Relationship; Vero Cells | 2016 |
New lipophilic isoniazid derivatives and their 1,3,4-oxadiazole analogues: Synthesis, antimycobacterial activity and investigation of their mechanism of action.
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Hep G2 Cells; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxadiazoles; Tuberculosis | 2018 |
Design, synthesis and in silico study of pyridine based 1,3,4-oxadiazole embedded hydrazinecarbothioamide derivatives as potent anti-tubercular agent.
Topics: Antitubercular Agents; Catalytic Domain; Cytochrome P450 Family 51; Drug Design; Free Radical Scavengers; Isoniazid; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Oxadiazoles; Protein Binding; Pyridines; Rifampin; Structure-Activity Relationship; Thiosemicarbazones | 2019 |
Synthesis, Characterization, and Biologic Activity of New Acyl Hydrazides and 1,3,4-Oxadiazole Derivatives.
Topics: Anti-Infective Agents; Antineoplastic Agents; Antitubercular Agents; Arylamine N-Acetyltransferase; Benzoates; Carboxylic Acids; Drug Evaluation, Preclinical; G1 Phase; Gene Expression Regulation; Humans; Hydrazines; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxadiazoles; RNA, Messenger | 2020 |
Phenoxyalkylimidazoles with an oxadiazole moiety are subject to efflux in Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Bacterial Proteins; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Humans; Isoniazid; Membrane Transport Proteins; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxadiazoles; Phenols; Reserpine | 2021 |
Synthesis, characterization, anti-mycobacterial activity and in silico study of new 2,5-disubstituted-1,3,4-oxadiazole derivatives.
Topics: Antitubercular Agents; Isoniazid; Ligands; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxadiazoles | 2022 |